Gout medication reduces major cardiovascular events in heart patients

Gout medication reduces major cardiovascular events in heart patients

Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.

Read the Original Article>>

Source: News Medical Life Sciences

Send this to a friend